GSK plc GSK on Monday reported interim results from its registrational Phase 2 AZUR-1 trial of Jemperli (dostarlimab) in ...

July 13 (Reuters) - GSK said on Monday its cancer drug Jemperli met the primary goal of a mid-stage trial, with a clinically ...

GSK's pivotal AZUR-1 trial of cancer immunotherapy Jemperli, as a way to delay or eliminate surgery in pre-operative rectal ...

In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers have unveiled a breakthrough showing that a subset of ...

Having an ostomy is a dreaded prospect for many patients with rectal cancer. To defer, and potentially avoid, this life-altering surgery, the watch-and-wait approach has become increasingly common ...

Magnetic resonance imaging (MRI) can spare many patients with rectal cancer from invasive surgery that can carry lifelong side effects, new research indicates. That information could be extremely ...

A new study shows that robotic surgery provides several important advantages over the laparoscopic approach to colorectal resections. The retrospective cohort study, published in the Journal of ...

Commonwealth Health Physician Network announced William Auriemma, M.D. — a member of the medical staff at Regional Hospital of Scranton — joined its provider team and is now accepting new patients in ...

Postoperative insulin resistance developed to a similar extent in both the open surgery and minimally invasive surgery (MIS) groups. The surgical approach did not significantly af ...

A study has found that the risk of developing dyslipidemia after surgery for colorectal cancer varies depending on where the ...